KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vir Biotechnology (VIR) Gains from Sales and Divestitures (2018 - 2022)

Vir Biotechnology's Gains from Sales and Divestitures history spans 5 years, with the latest figure at $349496.0 for Q4 2022.

  • On a quarterly basis, Gains from Sales and Divestitures rose 291.54% to $349496.0 in Q4 2022 year-over-year; TTM through Dec 2022 was $349496.0, a 291.54% increase, with the full-year FY2022 number at $349496.0, up 291.54% from a year prior.
  • Gains from Sales and Divestitures hit $349496.0 in Q4 2022 for Vir Biotechnology, up from $216886.0 in the prior quarter.
  • Over the last five years, Gains from Sales and Divestitures for VIR hit a ceiling of $2.2 million in Q4 2018 and a floor of $52963.0 in Q1 2021.
  • Historically, Gains from Sales and Divestitures has averaged $1.1 million across 5 years, with a median of $924352.0 in 2020.
  • Biggest five-year swings in Gains from Sales and Divestitures: plummeted 91.43% in 2021 and later surged 309.5% in 2022.
  • Tracing VIR's Gains from Sales and Divestitures over 5 years: stood at $2.2 million in 2018, then decreased by 11.63% to $2.0 million in 2019, then fell by 9.79% to $1.8 million in 2020, then crashed by 95.02% to $89261.0 in 2021, then surged by 291.54% to $349496.0 in 2022.
  • Business Quant data shows Gains from Sales and Divestitures for VIR at $349496.0 in Q4 2022, $216886.0 in Q1 2022, and $89261.0 in Q4 2021.